Navigation Links
Diabetes II May Be Controlled By Sanofi's New Obesity Pill

Sanofi-Aventis' Accomplia (rimonabant), a new drug for treatment of obesity, has been found to control blood sugar and reduce risk of cardiac problems// in people with diabetes type 2. The research was done on 1,047 overweight or obese patients with type 2 diabetes in Europe and south and North America.

Some of them were given 5 or 20 mg/day of rimonabant, while the others were treated with a placebo, for a 1 year period. Those on the drug showed a vast improvement in terms of weight loss, abdominal fat and waist size reduction and controlled blood sugar levels, and better appetite.

Professor Andre Scheen of the University of Liege in Belgium said that these findings support the usage of 20 mg of the drug daily, along with diet and exercise for treating the disease. The findings have been published online by the Lancet Medical Journal.

These effects of Accomplia reduce the risk of heart disease , stroke, renal damage, blindness and neuropathy which can lead to amputation of the foot. About 194 million people worldwide have diabetes mostly of the type 2 variety . This type is caused by an inability to regulate the glucose in the body properly, and is linked to being overweight or obese.

The standard drugs used are effective in controlling blood sugar levels but lead to weight gain, which makes the illness difficult to treat. Accomplia with its cardiovascular and metabolic effect could prove to be very useful , felt Scheen. It is generally well tolerated , the side effects being nausea, vomiting and anxiety.

The drug has a potential sales of over $3 billion worldwide and Sanofi considers it as its most promising new drug. It is being marketed in Britain, Denmark, Germany, Norway, Ireland, Finland and Austria.
MAL
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... in Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies ... these scam operations to a halt. According to Texas Premier Locksmith, these fraudulent ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... The medical ... holidays and winter seasons. One major study analyzing heart attacks among 138,602 people ... August of a given year. We would all agree of course–no time of year ...
(Date:12/7/2016)... Ohio (PRWEB) , ... December 07, 2016 , ... ... in the 2016 BOC Business Brilliance Awards under the Best New Product Launch ... and results achieved through user experience. , BOC Global Events & Training Group ...
(Date:12/7/2016)... ... 2016 , ... Maureen McLaughlin, LA.c., a certified acupuncturist, is ... Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility patients to ... their family building goals. Acupuncture helps fertility patients by supporting the ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)...  Lannett Company, Inc. (NYSE: LCI ) today announced ... Prescription for Success Healthcare Conference on December 14, 2016 at 9:20 ... York City . In addition, the company will ... 4 th Annual Boston Healthcare Conference taking place on December ... ...
(Date:12/6/2016)... CONCORD, Mass. , Dec. 6, 2016  Alopexx ... of DI-Leu16-IL2, a recombinant antibody fusion protein (immunocytokine) composed ... antibody recognizes the same target on B cells as ... and cytokine components but is also involved in tumor ... an anti-cancer vaccine effect. The results of the study ...
(Date:12/6/2016)... , Dec. 6, 2016 Diabetes & Obesity ... diabetes and obesity disease cluster is currently dominated by ... type 2 diabetes mellitus (T2DM), and the majority of ... of products, is attributable to these indications. While products ... market presence, there are a large number of these ...
Breaking Medicine Technology: